Klaviyo Insider Sold Shares Worth $4,035,088, According to a Recent SEC Filing-February 2024-www.financetom.com

Klaviyo Insider Sold Shares Worth $4,035,088, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Klaviyo Insider Sold Shares Worth $4,035,088, According to a Recent SEC Filing

Oct 9, 2025 1:24 PM

04:08 PM EDT, 10/09/2025 (MT Newswires) -- Andrew Bialecki, 10% Owner, Director, Chief Executive Officer, on October 07, 2025, sold 159,508 shares in Klaviyo ( KVYO ) for $4,035,088.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1835830/000199109925000003/xslF345X05/wk-form4_1760040098.xml

Previous page： MicroStrategy Closes $2 Billion Offering of Senior Notes Due 2030 Next page： Starbucks to Cut 1,100 Jobs, Eliminate Hundreds of Unfilled Positions

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

MicroStrategy Closes $2 Billion Offering of Senior Notes Due 2030

Feb 24, 2025

12:52 PM EST, 02/24/2025 (MT Newswires) -- MicroStrategy ( MSTR ) said Monday it completed its private offering of $2 billion of 0% convertible senior notes due March 1, 2030. The company also said it gave the initial buyers a five business-day option to purchase up to an additional $300 million total principal amount of the notes. The net proceeds...

Starbucks to Cut 1,100 Jobs, Eliminate Hundreds of Unfilled Positions

Feb 24, 2025

12:57 PM EST, 02/24/2025 (MT Newswires) -- Starbucks ( SBUX ) said Monday that it's cutting 1,100 non-retail support partner roles and eliminating several hundred unfilled positions as part of an effort to simplify the organization's structure. The move stems from the company's Back to Starbucks ( SBUX ) transformation plan and comes after Chief Executive Brian Niccol said last...

Pfizer Appoints Patrizia Cavazzoni as Chief Medical Officer

Feb 24, 2025

01:01 PM EST, 02/24/2025 (MT Newswires) -- Pfizer ( PFE ) said Monday Patrizia Cavazzoni will be rejoining the company as chief medical officer. Cavazzoni was most recently the director of the Center for Drug Evaluation and Research at the US Food and Drug Administration, Pfizer ( PFE ) said. Cavazzoni will succeed Aida Habtezion who will be leaving Pfizer...

Global fragrance makers must face price-fixing case, US judge rules

Feb 24, 2025

Feb 24 (Reuters) - Four European and American fragrance makers must face lawsuits accusing them of conspiring to inflate prices of ingredients used to make cosmetics, cleaners and other household products, a federal judge in New Jersey has ruled. U.S. District Judge William Martini on Friday rejected efforts by the companies - Switzerland-based Givaudan and Firmenich, which has merged with...